SciPro is working on a search for a Director, Biostatistics for a unique Biotech we're incredibly excited to be taking to market and have worked with previously. They're a new kind of therapeutics company existing at the intersection of ML, biological engineering, and medicine to create breakthrough medicines. They have a proprietary platform that can generate medicines on demand across multiple therapeutic modalities with unprecedented speed and success rates, representing a fundamental shift in drug discovery. They've always been at the forefront of integrating GenAI/ML in drug discovery and this opportunity offers the ability to get as close as it gets to creating a therapeutic. They currently have 18 programs, 2 of them have been filed and financially they have raised over $700m over their 4 years of their existence, with their last Series C funding nearly at $280m. In this role you will report to the Head of Biometrics and is a new role within the Biometrics group. You will be successful in this role should you have the following qualifications: Industry experience (Pharma & Biotech preferred) with 8+ years' experience (PhD) or 10+ years' experience (Masters)Need this candidate to still be hands-on, strong R skills (SAS is ok)Thorough understanding of what end points are needed, SAPs, and ideally Phase II/III designEarly phase experience, ideally experienced with translational biostatisticsAbility to act independently and explain statistical concepts to cross-functional groupsIt's important the candidate understands overall clinical study programsHigh EQExcellent communication and human skillsCompetencies: rigorous, accountable, ability to work in a small company and step up/take ownership and a strong team player You will have high visibility into the work of cross-functional teams, senior leadership discussions on the company's direction, programs and strategy. They have tripled in size in the past 2 years and with no signs of slowing down, and are looking for an entrepreneurial Biostatistician to join their collaborative and ambitious team!

This ground-breaking biotech that is dedicated to the advancement of RNA therapies targeting chronic liver diseases is actively seeking a Senior Scientist to join their team. This company employs a blend of genomic deep phenotyping, precision RNA medicine, and experimentation utilizing live human donor livers to address significant challenges in liver health, including augmenting donor liver availability and mitigating complications arising from cirrhosis.This company is headquartered out of the UK but has a flagship location in New York City and this role will report directly into the Head of the R&D site. Responsibilities:Drive innovation through the development and implementation of cutting-edge phenotyping strategies, in-vitro assay development, and molecular and cellular biology techniques.Spearhead the design and execution of experimental plans, actively engaging in perfusion workflows.Analyze, evaluate, and interpret data and results derived from experiments.Foster active collaboration and communication with international team members.Qualifications:PhD in Life Sciences/Bioscience with 2-3 years of experience.Proficient in conducting laboratory assays including qPCR, western blots, immunofluorescence, cell-based assays, and flow cytometry.Skilled in handling omics technologies such as proteomics, metabolomics, and transcriptomics.Experienced in histology, including sample preparation and basic image analysis.Disease biology expertise with liver biology is preferred.

Head of Clinical Pharmacology & DMPK SciPro has partnered with a small molecule, stealth biotech backed by a top-tier Venture Capital firm, offering a highly collaborative and entrepreneurial environment. Focused on targeting cholesterol homeostasis, we are advancing multiple CNS therapeutic programs and scaling towards NDA filings. They are seeking an experienced Head of Clinical Pharmacology & DMPK to lead and own their Clinical Pharmacology function across all phases of development (IND, Phase I-III, and NDA filings). This role reports directly to the Chief Scientific Officer (CSO) and offers the opportunity to make a significant impact on our programs as we prepare for Phase 2 Proof-of-Concept (POC) studies and NDA submissions. Key Responsibilities:Lead and own the Clinical Pharmacology function for NDA submission and oversee all related Nonclinical activities.Develop in vitro and in vivo ADME screening and DMPK study plans for early research programs.Support dosing decisions and interpret data using PK software.Collaborate with and oversee external parties for modeling work and data interpretation.Partner with the CSO and leadership team to drive development and execution of clinical studies.Contribute to the growth and scaling of a rapidly evolving biotech, bringing hands-on expertise and leadership. Qualifications:PhD and 10+ years of experience in the pharmaceutical indsutry.Extensive experience in Clinical Pharmacology & DMPK, with a proven track record of supporting IND through NDA stages.Expertise in in vitro and in vivo ADME screening, DMPK study plans, and dosing strategies.Proficient in PK software and data interpretation.Experience collaborating with external partners for modeling and related activities.A self-starter and "builder" mindset, with the ability to adapt and thrive in a fast-paced biotech environment. What They Offer:The chance to work with a highly successful and visionary C-Suite leadership team.A stable financial backing, with ongoing funding rounds to support clinical advancements.The opportunity to shape the future of CNS therapies in a mission-driven, innovative organization.

SciPro is partnered with an innovative drug discovery biotech in the NYC area. The person selected will serve as a key leader managing CRO's & consultants on toxicology studies for various modalities. Responsibilities:Provide leadership on toxicology programs from discovery to clinical developmentDesign & develop in vivo/in vitro toxicity studiesOversee pre-clinical studies at CROManage CRO teams and consultants Qualifications:PhD & 8 + years of industry experienceExperience working in or managing CRO'sExperience working on biologics & small molecule toxicology programsIND filing experience All interested applicants are encouraged to apply below.

SciPro has partnered with a leading pharmaceutical organization that is seeking an experienced scientist to lead ADME efforts within a multidisciplinary team. This role focuses on advancing drug discovery and development through experimental design, data interpretation, and collaboration across various functions, contributing to regulatory submissions and therapeutic innovations. Key Responsibilities:Deliver integrated data packages for compound selection, study design, and regulatory submissions.Collaborate across Discovery and Development teams to optimize ADME properties and advance drug candidates.Design and support nonclinical and clinical studies, ensuring regulatory compliance.Lead R&D initiatives to enhance ADME/DMPK capabilities across drug modalities.Integrate in vitro, in vivo, and in silico ADME data to refine structure-activity relationships.Represent ADME in regulatory discussions and guide scientists on modern ADME principles. Qualifications:Ph.D. in Pharmacokinetics, Pharmacology, Pharmaceutics, Biochemistry, or related field with 6+ years of experience.Strong expertise in drug metabolism, disposition, and pharmacokinetics (discovery and development).Experience with molecular modalities (e.g., biologics, peptides, oligonucleotides).Proficiency in modeling software (e.g., SimCYP, GastroPlus).Excellent communication, collaboration, and project management skills. Additional Information: This opportunity offers a chance to drive innovation and impact patient care while collaborating with a passionate R&D team.